| Financial Year |
March 31 2023 |
| Monetary Funds |
106,838,210.58 |
| Held-for-trading Financial Assets |
338,692,842.40 |
| Notes Receivable |
-- |
| Accounts Receivable |
167,261,948.75 |
| Advances to Suppliers |
14,464,308.22 |
| Other Receivables |
3,018,974.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
148,935,962.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,310,885.78 |
| Total Current Assets |
843,457,615.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,058,682.04 |
| Fixed Assetes |
419,251,329.21 |
| Under-construction Projects |
117,125,165.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,873,146.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,990,537.04 |
| Deferred Income Tax Assets |
11,427,642.85 |
| Other Non-Current Assets |
8,548,488.02 |
| Sub-Total of Non-Current Assets |
747,757,474.81 |
| Total Assets |
1,591,215,090.44 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
162,683,458.22 |
| Accounts Payable |
164,224,200.44 |
| Accounts Received In Advance |
103,112.36 |
| Employee Compensation Payable |
21,273,912.27 |
| Taxes Payable |
4,810,209.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,180,780.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,474,981.34 |
| Other Current Liabilities |
85,481.93 |
| Sub-Total of Current Liabilities |
384,049,753.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,047,779.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,187,046.01 |
| Total Liabilities |
407,236,799.52 |
| Paid-In Capital(Or Share Stock) |
156,000,000.00 |
| Capital Surplus |
320,530,108.39 |
| Surplus Reserve |
78,000,000.00 |
| LESS:Treasury Stock |
44,985,229.32 |
| Undistributed Profits |
582,992,023.03 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,183,978,290.92 |
| Owner's Equity（Stockholder's Equity） |
1,183,978,290.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,591,215,090.44 |
